HELIX ACQUISITION CORP's ticker is HLXA and the CUSIP is G4444C102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,521,000 | +2.5% | 137,000 | -8.7% | 2.58% | +166.5% |
| Q4 2021 | $1,484,000 | -0.3% | 150,000 | 0.0% | 0.97% | +18.8% |
| Q3 2021 | $1,489,000 | -4.1% | 150,000 | 0.0% | 0.82% | +335.8% |
| Q2 2021 | $1,552,000 | +1.4% | 150,000 | 0.0% | 0.19% | +14.7% |
| Q1 2021 | $1,530,000 | -9.2% | 150,000 | 0.0% | 0.16% | +3.8% |
| Q4 2020 | $1,685,000 | – | 150,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 500,000 | $5,175,000 | 1.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 234,020 | $2,422,000 | 1.08% |
| Foresite Capital Management V, LLC | 250,000 | $2,588,000 | 1.02% |
| Octagon Capital Advisors LP | 400,000 | $4,132,000 | 0.86% |
| Finepoint Capital LP | 350,000 | $3,616,000 | 0.68% |
| Altium Capital Management LP | 250,000 | $2,588,000 | 0.60% |
| STALEY CAPITAL ADVISERS INC | 500,000 | $5,175,000 | 0.27% |
| Consonance Capital Management LP | 150,000 | $1,552,000 | 0.19% |
| Bain Capital Life Sciences Investors, LLC | 250,000 | $2,588,000 | 0.17% |
| Cormorant Asset Management, LP | 430,000 | $4,450,000 | 0.15% |